33092647|t|Association of ABI3 and PLCG2 missense variants with disease risk and neuropathology in Lewy body disease and progressive supranuclear palsy.
33092647|a|Missense variants ABI3_rs616338-T and PLCG2_rs72824905-G were previously associated with elevated or reduced risk of Alzheimer's disease (AD), respectively. Despite reports of associations with other neurodegenerative diseases, there are few studies of these variants in purely neuropathologically diagnosed cohorts. Further, the effect of these mutations on neurodegenerative disease pathologies is unknown. In this study, we tested the effects of ABI3_rs616338-T and PLCG2_rs72824905-G on disease risk in autopsy cohorts comprised of 973 patients diagnosed neuropathologically with Lewy body disease (LBD-NP) and 1040 with progressive supranuclear palsy (PSP), compared to 3351 controls. LBD-NP patients were further categorized as high, intermediate and low likelihood of clinical dementia with Lewy bodies (DLB-CL) based on DLB Consortium criteria. We also tested for association with both Braak neurofibrillary tau tangle (nTotal = 2008, nPSP = 1037, nLBD-NP = 971) and Thal phase amyloid plaque scores (nTotal = 1786, nPSP = 1018, nLBD-NP = 768). Additionally, 841 PSP patients had quantitative tau neuropathology measures that were assessed for genetic associations. There was no statistically significant association with disease risk for either LBD-NP or PSP in our study. LBD intermediate category disease risk was significantly associated with ABI3_rs616338-T (OR = 2.65, 95% CI 1.46-4.83, p = 0.001). PLCG2_rs72824905-G was associated with lower Braak stage (ss = - 0.822, 95% CI - 1.439 to - 0.204, p = 0.009). This effect was more pronounced in the PSP (ss = - 0.995, 95% CI - 1.773 to - 0.218, p = 0.012) than LBD-NP patients (ss = - 0.292, 95% CI - 1.283 to 0.698, p = 0.563). PLCG2_rs72824905-G also showed association with reduced quantitative tau pathology for each lesion type and overall tau burden in PSP (ss = - 0.638, 95% CI - 1.139 to - 0.136, p = 0.013). These findings support a role for PLCG2_rs72824905-G in suppressing tau neuropathology. ABI3_rs616338-T may influence disease risk specifically in the LBD-NP intermediate category comprised of patients with diffuse neocortical or limbic LB, concurrently with moderate or high AD neuropathology, respectively. Our study provides a potential mechanism of action for the missense PLCG2 variant and suggests a differential disease risk effect for ABI3 in a distinct LBD-NP neuropathologic category.
33092647	15	19	ABI3	Gene	51225
33092647	24	29	PLCG2	Gene	5336
33092647	88	105	Lewy body disease	Disease	MESH:D020961
33092647	110	140	progressive supranuclear palsy	Disease	MESH:D013494
33092647	160	164	ABI3	Gene	51225
33092647	165	173	rs616338	SNP	tmVar:rs616338;VariantGroup:0;CorrespondingGene:51225;RS#:616338;CorrespondingSpecies:9606
33092647	180	185	PLCG2	Gene	5336
33092647	186	196	rs72824905	SNP	tmVar:rs72824905;VariantGroup:1;CorrespondingGene:5336;RS#:72824905;CorrespondingSpecies:9606
33092647	259	278	Alzheimer's disease	Disease	MESH:D000544
33092647	280	282	AD	Disease	MESH:D000544
33092647	342	368	neurodegenerative diseases	Disease	MESH:D019636
33092647	501	526	neurodegenerative disease	Disease	MESH:D019636
33092647	591	595	ABI3	Gene	51225
33092647	596	604	rs616338	SNP	tmVar:rs616338;VariantGroup:0;CorrespondingGene:51225;RS#:616338;CorrespondingSpecies:9606
33092647	611	616	PLCG2	Gene	5336
33092647	617	627	rs72824905	SNP	tmVar:rs72824905;VariantGroup:1;CorrespondingGene:5336;RS#:72824905;CorrespondingSpecies:9606
33092647	682	690	patients	Species	9606
33092647	726	743	Lewy body disease	Disease	MESH:D020961
33092647	745	751	LBD-NP	Disease	MESH:D020192
33092647	767	797	progressive supranuclear palsy	Disease	MESH:D013494
33092647	799	802	PSP	Disease	MESH:D013494
33092647	832	838	LBD-NP	Disease	MESH:D020192
33092647	839	847	patients	Species	9606
33092647	926	951	dementia with Lewy bodies	Disease	MESH:D020961
33092647	953	959	DLB-CL	Disease	MESH:D020961
33092647	970	973	DLB	Disease	MESH:D020961
33092647	1042	1068	neurofibrillary tau tangle	Disease	MESH:D055956
33092647	1128	1135	amyloid	Disease	MESH:C000718787
33092647	1213	1216	PSP	Disease	MESH:D013494
33092647	1217	1225	patients	Species	9606
33092647	1243	1261	tau neuropathology	Disease	MESH:C536599
33092647	1396	1402	LBD-NP	Disease	MESH:D020192
33092647	1406	1409	PSP	Disease	MESH:D013494
33092647	1424	1427	LBD	Disease	MESH:D020192
33092647	1497	1501	ABI3	Gene	51225
33092647	1502	1510	rs616338	SNP	tmVar:rs616338;VariantGroup:0;CorrespondingGene:51225;RS#:616338;CorrespondingSpecies:9606
33092647	1555	1560	PLCG2	Gene	5336
33092647	1561	1571	rs72824905	SNP	tmVar:rs72824905;VariantGroup:1;CorrespondingGene:5336;RS#:72824905;CorrespondingSpecies:9606
33092647	1705	1708	PSP	Disease	MESH:D013494
33092647	1767	1773	LBD-NP	Disease	MESH:D020192
33092647	1774	1782	patients	Species	9606
33092647	1835	1840	PLCG2	Gene	5336
33092647	1841	1851	rs72824905	SNP	tmVar:rs72824905;VariantGroup:1;CorrespondingGene:5336;RS#:72824905;CorrespondingSpecies:9606
33092647	1904	1907	tau	Gene	4137
33092647	1951	1954	tau	Gene	4137
33092647	1965	1968	PSP	Disease	MESH:D013494
33092647	2057	2062	PLCG2	Gene	5336
33092647	2063	2073	rs72824905	SNP	tmVar:rs72824905;VariantGroup:1;CorrespondingGene:5336;RS#:72824905;CorrespondingSpecies:9606
33092647	2091	2109	tau neuropathology	Disease	MESH:C536599
33092647	2111	2116	ABI3_	Gene	51225
33092647	2116	2124	rs616338	SNP	tmVar:rs616338;VariantGroup:0;CorrespondingGene:51225;RS#:616338;CorrespondingSpecies:9606
33092647	2174	2180	LBD-NP	Disease	MESH:D020192
33092647	2216	2224	patients	Species	9606
33092647	2260	2262	LB	Disease	
33092647	2299	2301	AD	Disease	MESH:D000544
33092647	2400	2405	PLCG2	Gene	5336
33092647	2466	2470	ABI3	Gene	51225
33092647	2485	2491	LBD-NP	Disease	MESH:D020192
33092647	Positive_Correlation	MESH:D020192	RS#:616338;CorrespondingGene:51225
33092647	Positive_Correlation	MESH:D000544	RS#:616338;CorrespondingGene:51225
33092647	Negative_Correlation	MESH:D000544	RS#:72824905;CorrespondingGene:5336
33092647	Association	MESH:D000544	51225
33092647	Negative_Correlation	MESH:D000544	5336
33092647	Association	MESH:D013494	5336
33092647	Association	MESH:D020192	51225
33092647	Association	MESH:D020961	5336
33092647	Association	MESH:D020192	51225
33092647	Association	MESH:D000544	51225
33092647	Association	MESH:D000544	5336

